A New or Changing Mole — a Decision, Not a Reassurance

What to do the moment you notice a new or changing mole

The first move is to document it, not to diagnose it. Photograph the spot in bright, even light with a ruler or a coin beside it for scale, record the date, and then arrange to have it examined — within a few weeks for most changing moles, and sooner if it is bleeding, growing quickly, or brand new in adulthood. Documentation turns a vague worry into something a clinician can measure against later.

Good mole tracking is simple: one photo is a baseline, and two photos taken a few weeks apart show whether a spot is evolving — which is the single most useful thing you can walk into a visit holding. Serial photography of a pigmented lesion beats memory every time, because the eye adjusts to slow change and stops noticing it. The mistake this hub exists to prevent is the open-ended wait-and-see loop, the one with no endpoint. Pick an actual date to be seen and put it on the calendar. If the spot is changing week to week, that date should be close.

The ABCDE signs — and what they are for

ABCDE is the plain-language checklist for melanoma warning signs: Asymmetry (one half unlike the other), Border irregularity, Color that varies within the spot, Diameter greater than about 6 millimeters (a pencil eraser), and Evolving — any change over time 1Ref 1Tsao H, Olazagasti JM, Cordoro KM, et al. (2015).Early detection of melanoma: reviewing the ABCDEs.The ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter over ~6 mm, Evolving) are clinical features that flag a pigmented lesion for closer melanoma evaluation, including new or changing lesions.. It was built to help ordinary people and clinicians flag lesions that deserve a closer look, and 'Evolving' was added to the original list because change proved to be one of the most reliable signals 2Ref 2Abbasi NR, Shaw HM, Rigel DS, et al. (2004).Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.'Evolving' was added to the original ABCD criteria because change over time is a key early-melanoma signal, and the greater-than-6 mm diameter criterion was retained..

Each letter points at a different property. Asymmetry: an imaginary line through the middle leaves two halves that do not match. Border: the edge is notched, scalloped, or blurred rather than smooth and sharp. Color: more than one shade in the same spot — browns and blacks, sometimes red, white, or blue-gray. Diameter: larger than a pencil eraser, though a melanoma can be smaller than that. Evolving: any change in size, shape, color, or elevation, or a new symptom such as itching or bleeding 1Ref 1Tsao H, Olazagasti JM, Cordoro KM, et al. (2015).Early detection of melanoma: reviewing the ABCDEs.The ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter over ~6 mm, Evolving) are clinical features that flag a pigmented lesion for closer melanoma evaluation, including new or changing lesions.. Evolving is listed last but often carries the most weight, which is exactly why a dated photo is worth more than a careful once-over.

The letters are a prompt to act, not a scoring system that clears a spot. A lesion can be a melanoma with only one of the five features, and some melanomas show none of the classic five at all — they can be small, symmetric, or a single flat color. ABCDE tells you when to get a spot seen; it never tells you that a spot is safe. Treat any letter that fits as a reason to book the exam, and treat the absence of all five as no guarantee. This is where a page has to stop and a clinician has to start.

Why 'changing' matters more than any single feature

Change over time — the E in ABCDE — is the signal that most often catches melanoma, and it is why documentation beats a one-time inspection. A mole that is getting bigger and darker, developing new colors, rising off the skin, itching, or bleeding has declared itself worth evaluating regardless of how it scores on the other letters 1Ref 1Tsao H, Olazagasti JM, Cordoro KM, et al. (2015).Early detection of melanoma: reviewing the ABCDEs.The ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter over ~6 mm, Evolving) are clinical features that flag a pigmented lesion for closer melanoma evaluation, including new or changing lesions.2Ref 2Abbasi NR, Shaw HM, Rigel DS, et al. (2004).Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.'Evolving' was added to the original ABCD criteria because change over time is a key early-melanoma signal, and the greater-than-6 mm diameter criterion was retained.. Stability over years is reassuring; recent change is not.

The companion idea is the ugly duckling sign: most of a person's moles resemble one another, so the one that looks clearly different from the rest is the outlier worth attention. Your own moles are the reference set, which is exactly why a personal baseline — a set of photos, or a clinician's map — makes the odd one out obvious. A spot does not have to be dramatic to matter. It has to be different from your normal, or different from what it was a month ago. Either kind of difference is a reason to be seen, not a reason to keep watching.

New moles in adulthood, and having many moles

Most moles appear in childhood, the teens, and the twenties. A genuinely new mole after 40 is less expected, and clinicians generally treat a new or newly changing pigmented spot in an adult as a reason to examine it — a brand-new lesion is itself a form of the 'Evolving' that ABCDE flags 1Ref 1Tsao H, Olazagasti JM, Cordoro KM, et al. (2015).Early detection of melanoma: reviewing the ABCDEs.The ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter over ~6 mm, Evolving) are clinical features that flag a pigmented lesion for closer melanoma evaluation, including new or changing lesions.. That does not mean it is cancer. It means it has earned a look rather than a wait.

Whether having many moles raises your risk, and whether a set of unusual, atypical ones matters, is a fair question to take to a baseline skin exam — the place where a clinician can map what is normal for you and note anything worth watching. That personal baseline is what later makes an ugly-duckling spot stand out. A family history of melanoma, fair skin that burns easily, or a lot of past sun and tanning-bed exposure all belong in that conversation, because they help a clinician decide how closely to follow you. The point is not to self-score your risk; it is to give a professional the context to set the plan.

Why this page cannot tell you whether it is cancer

No article, and no photo, can diagnose a mole. Melanoma and harmless moles overlap in how they look, and the features that separate them are often visible only under magnification in a clinician's hands, or settled only by a biopsy. That is the honest limit of a page like this one: it can tell you the signs that warrant a visit and how quickly to go, but it cannot hand you the verdict 1Ref 1Tsao H, Olazagasti JM, Cordoro KM, et al. (2015).Early detection of melanoma: reviewing the ABCDEs.The ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter over ~6 mm, Evolving) are clinical features that flag a pigmented lesion for closer melanoma evaluation, including new or changing lesions..

Telling melanoma vs a normal mole apart by eye is exactly what trips people up, which is why a clear description online is not the same as a clear diagnosis. A mole check online through teledermatology can genuinely help — a photo review can triage a spot and flag it for in-person evaluation, and there are published standards for the image quality and security such reviews should meet 3Ref 3American Academy of Dermatology (2024).Teledermatology Standards.Teledermatology is delivered under AAD standards for image quality and platform security; a store-and-forward photo review can triage a lesion but has technical limits compared with an in-person exam.. But the limits are real: a photograph misses texture, misses the dermatoscopic detail a clinician sees up close, and cannot take a biopsy. A reassuring remote read is a reason to keep an eye on a spot, not a reason to cross it off. If a lesion worries you, an in-person exam is still the endpoint.

How fast should you be seen?

The timeframe depends on the signal. A spot that is rapidly changing, bleeding, ulcerated, or a new firm bump that is growing is a see-soon situation — days to a couple of weeks, and worth calling to ask for an earlier slot. A mole with one or two ABCDE features but no rapid change still warrants evaluation, generally within a few weeks. A stable, unchanged mole you have had for years is the lowest priority, though a baseline photo is still worth taking.

Practically, that visit can start with a primary care clinician or a dermatologist; if the wait is long, it is reasonable to ask the office to note that this is a changing pigmented lesion and to add you to a cancellation list. One nuance often gets misread: routine whole-body skin screening of adults who have no symptoms is a separate and unsettled question — the US Preventive Services Task Force found the evidence insufficient to recommend for or against it 4Ref 4US Preventive Services Task Force (2023).Skin Cancer: Screening.The USPSTF found current evidence insufficient to assess the balance of benefits and harms of routine clinician visual whole-body skin screening in asymptomatic adults; this does not address evaluation of a concerning lesion.. That finding is about screening people with nothing to report. It says nothing about getting a spot that concerns you evaluated, and it is not a reason to wait on a mole that is changing.

What happens at the visit

A clinician examines the spot with the naked eye and often a dermatoscope, compares it against your other moles and any photos you brought, and decides whether it can be safely watched or should be sampled. If there is enough concern, the next step is a skin biopsy — removing the lesion or a full-thickness portion of it so a pathologist can examine the cells 5Ref 5Swetter SM, Tsao H, Bichakjian CK, et al. (2019).Guidelines of care for the management of primary cutaneous melanoma.Melanoma is diagnosed by biopsy, with excisional or narrow-margin full-thickness sampling preferred over a superficial shave to preserve depth measurement and staging accuracy.. The pathology, not the appearance, is what produces a diagnosis.

For a suspected melanoma, guidelines favor sampling the whole lesion rather than taking a thin superficial shave, so that the depth of the tumor can be measured — that measurement drives everything that follows 5Ref 5Swetter SM, Tsao H, Bichakjian CK, et al. (2019).Guidelines of care for the management of primary cutaneous melanoma.Melanoma is diagnosed by biopsy, with excisional or narrow-margin full-thickness sampling preferred over a superficial shave to preserve depth measurement and staging accuracy.. A biopsy is a small procedure done under local anesthesia, and being sent for one is routine rather than a sign the news is bad; most biopsied moles turn out to be benign. The purpose of the visit is to convert uncertainty into an answer, and an answer is worth far more than a guess you carry around for months.

If a biopsy is taken, the sample goes to a pathologist and the result usually comes back within several days, sometimes longer when special stains are needed. Waiting for that report is the hard part, but it is also the whole point: the report turns a spot that worried you into a named diagnosis with a clear next step — which may be nothing further, a wider removal to take a margin around the site, or a referral. Either way, you stop guessing.

Why early detection is worth the trip

Melanoma found early, while it is thin and confined to the skin, is highly treatable, and survival is strongly tied to how deep the tumor has grown by the time it is removed. That is the whole logic of documenting and evaluating a changing mole promptly — not fear, but the plain fact that the same cancer caught earlier is a very different situation from the same cancer caught late 6Ref 6National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025).Cancer Stat Facts: Melanoma of the Skin.US melanoma five-year relative survival is high when the disease is localized to the skin and markedly lower once it has spread to distant sites..

In US data, five-year relative survival for melanoma is high when the disease is still localized to the skin and markedly lower once it has spread to distant sites 6Ref 6National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program (2025).Cancer Stat Facts: Melanoma of the Skin.US melanoma five-year relative survival is high when the disease is localized to the skin and markedly lower once it has spread to distant sites.. Those numbers are the argument for a few weeks of attention now, and they are also the reason not to spiral: catching a spot early is exactly what the documentation-and-visit routine is designed to do. Most spots people bring in are not cancer, and the usual job of the visit is to reassure you with an examination rather than leave you guessing. The goal is not to frighten you into the clinic. It is to make the trip, so that whatever the spot is, you know.